UPDATE ON GBM AGILE: A GLOBAL, PHASE 2/3 ADAPTIVE PLATFORM TRIAL TO EVALUATE MULTIPLE REGIMENS IN NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA

被引：0

作者：

Lassman, Andrew ^{[1
]}

Alexander, Brian ^{[2
]}

Berry, Donald ^{[3
]}

Berry, Nicholas ^{[3
]}

Buxton, Meredith ^{[4
]}

Colman, Howard ^{[5
]}

Gan, Hui ^{[6
]}

de Groot, John ^{[7
]}

de la Fuente, Macarena ^{[8
]}

Drappatz, Jan ^{[9
]}

Ducray, Francois ^{[10
]}

Ellingson, Benjamin ^{[11
]}

Gordon, Gary ^{[4
]}

Hyddmark, Emma ^{[4
]}

Johnson, Adam ^{[4
]}

Khasraw, Mustafa ^{[12
]}

Lee, Eudocia ^{[13
]}

Lim, Michael ^{[14
]}

Mcglothlin, Anna ^{[3
]}

Mellinghoff, Ingo ^{[15
]}

Mikkelsen, Tom ^{[16
]}

Nghiemphu, Phioanh ^{[11
]}

Perry, James ^{[17
]}

Powell, Ashley ^{[4
]}

Sulman, Erik ^{[18
]}

Tanner, Krik ^{[19
]}

Untch, Sarah ^{[4
]}

Weller, Michael ^{[20
,21
]}

Wen, Patrick ^{[13
]}

Wick, Antje ^{[22
]}

Yung, Alfred ^{[23
]}

Cloughesy, Timothy ^{[11
]}

机构：

[1] Columbia Univ, New York Presbyterian Hosp, Herbert Irving Comprehens Canc Ctr, Vagelos Coll Phys & Surg, New York, NY USA

[2] Dana Farber Brigham & Womens Canc Ctr, Boston, MA USA

[3] Berry Consultants LLC, Austin, TX USA

[4] Global Coalit Adapt Res, Larkspur, CA USA

[5] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA

[6] Austin Hlth, Melbourne, Australia

[7] UCSF, San Francisco, CA USA

[8] Univ Miami, Miller Sch Med, Miami, FL USA

[9] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA

[10] CHU Lyon, Lyon, France

[11] UCLA, Los Angeles, CA USA

[12] Duke Univ, Med Ctr, Durham, NC USA

[13] Dana Farber Canc Inst, Boston, MA USA

[14] Stanford Univ, Stanford, CA USA

[15] Mem Sloan Kettering, New York, NY USA

[16] Henry Ford, Detroit, MI USA

[17] Univ Toronto, Toronto, ON, Canada

[18] NYU, Grossman Sch Med, New York, NY USA

[19] Natl Brain Tumor Soc, Newton, MA USA

[20] Univ Hosp, Zurich, Switzerland

[21] Univ Zurich, Zurich, Switzerland

[22] Heidelberg Univ Hosp, Heidelberg, Germany

[23] Univ Texas MD Anderson Canc Ctr, Houston, TX USA

来源：

NEURO-ONCOLOGY | 2024年 / 26卷

关键词：

D O I：

10.1093/neuonc/noae165.0406

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

NOAE165.04

引用

页数：2

共 50 条

[1] UPDATE ON GBM AGILE: A GLOBAL, PHASE 2/3 ADAPTIVE PLATFORM TRIAL TO EVALUATE MULTIPLE REGIMENS IN NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA.
Buxton, Meredith
Alexander, Brian
Berry, Donald
Cavenee, Webster
Colman, Howard
de Groot, John
Ellingson, Benjamin
Gordon, Gary
Khasraw, Mustafa
Lassman, Andrew
Lee, Eudocia
Li, Wenbin
Lim, Michael
Mellinghoff, Ingo
Mikkelsen, Tom
Nelli, Apoorva
Perry, James
Sulman, Erik
Tanner, Kirk
Weller, Michael
Wen, Patrick Y.
Yung, W. K. Alfred
Cloughesy, Timothy
NEURO-ONCOLOGY, 2022, 24 : 80 - 80
[2] UPDATE ON GBM AGILE: A GLOBAL, PHASE 2/3 ADAPTIVE PLATFORM TRIAL TO EVALUATE MULTIPLE REGIMENS IN NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA.
Weller, M.
Alexander, B.
Berry, D.
Blondin, N.
Buxton, M.
Cavenee, W.
Colman, H.
de Groot, J.
De la Fuente, M.
Ducray, F.
Ellingson, B.
Gordon, G.
Hyddmark, E. M. V.
Khasraw, M.
Lassman, A.
Lee, E.
Lim, M.
Mellinghoff, I.
Mikkelsen, T.
Perry, J.
Sulman, E.
Tanner, K.
Wen, P.
Wick, A.
Yung, A.
Cloughesy, T.
NEURO-ONCOLOGY, 2023, 25
[3] GBM AGILE: A GLOBAL, PHASE 2/3 ADAPTIVE PLATFORM TRIAL TO EVALUATE MULTIPLE REGIMENS IN NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA
Buxton, Meredith
Alexander, Brian
Berry, Donald
Cavenee, Webster
Colman, Howard
de Groot, John
Ellingson, Benjamin
Gordon, Gary
Khasraw, Mustafa
Lassman, Andrew
Lee, Wenbin
Lim, Michael
Mellinghoff, Ingo
Perry, James
Sulman, Erik
Tanner, Kirk
Weller, Michael
Wen, Patrick
Yung, W. K. Alfred
Cloughesy, Timothy
NEURO-ONCOLOGY, 2020, 22 : 195 - 196
[4] GBM AGILE: A global, phase 2/3 adaptive platform trial to evaluate multiple regimens in newly diagnosed and recurrent glioblastoma
Mellinghoff, Ingo K.
Alexander, Brian
Berry, Donald
Blondin, Nicholas
Buxton, Meredith
Cavenee, Webster
Colman, Howard
de Groot, John
de la Fuente, Macarena I.
Ellingson, Benjamin
Gordon, Gary
Hyddmark, Emma M. V.
Khasraw, Mustafa
Lassman, Andrew
Lee, Eudocia
Li, Wenbin
Lim, Michael
Mikkelsen, Tom
Nelli, Apoorva
Perry, James
Sulman, Erik
Tanner, Kirk
Weller, Michael
Wen, Patrick Y.
Cloughesy, Timothy
CANCER RESEARCH, 2023, 83 (08)
[5] GBM AGILE: A global, phase 2/3 adaptive platform trial to evaluate multiple regimens in newly diagnosed and recurrent glioblastoma
Cloughesy, Timothy Francis
Alexander, Brian Michael
Berry, Donald A.
Colman, Howard
De Groot, John Frederick
Ellingson, Benjamin M.
Gordon, Gary B.
Khasraw, Mustafa
Lassman, Andrew B.
Lee, Eudocia Quant
Lim, Michael
Mellinghoff, Ingo K.
Nelli, Apoorva
Perry, James R.
Sulman, Erik P.
Tanner, Kirk
Weller, Michael
Wen, Patrick Y.
Yung, W. K. Alfred
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
[6] Update on GBM AGILE: A global, phase II/III adaptive platform trial to evaluate multiple regimens in newly diagnosed and recurrent glioblastoma
Weller, M.
Berry, D. A.
Blondin, N.
Buxton, M.
Colman, H.
de Groot, J. F.
de la Fuente, M.
Ducray, F.
Ellingson, B.
Gordon, G.
Lassman, A. B.
Lee, E.
Lim, M.
Mellinghoff, I.
Perry, J.
Sulman, E.
Yung, W-K. A.
Wen, P.
Wick, A.
Cloughesy, T.
ANNALS OF ONCOLOGY, 2024, 35 : S426 - S427
[7] GBM AGILE: A GLOBAL, PHASE 2/3 ADAPTIVE PLATFORM TRIAL TO EVALUATE MULTIPLE TREATMENT REGIMENS IN NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA
Weller, M.
Ellingson, B.
Alexander, B.
Wen, P.
Sulman, E.
Colman, H.
Berry, D.
Tanner, K.
Khasraw, M.
Lim, M.
Perry, J.
Lassman, A.
Cloughesy, T.
Yung, W. K. A.
Lee, E. Q.
Mellinghoff, I.
Gordon, G.
de Groot, J.
Mikkelsen, T.
Cavenee, W.
Nelli, A.
Buxton, M.
Li, W.
NEURO-ONCOLOGY, 2022, 24
[8] GBM AGILE: A global, phase 2/3 adaptive platform trial to evaluate multiple regimens in newly diagnosed and recurrent glioblastoma.
Wen, Patrick Y.
Mellinghoff, Ingo K.
Buxton, Meredith Becker
Cavenee, Webster K.
Colman, Howard
De Groot, John Frederick
Ellingson, Benjamin M.
Gordon, Gary B.
Khasraw, Mustafa
Lassman, Andrew B.
Lim, Michael
Perry, James R.
Tanner, Kirk
Weller, Michael
Yung, W. K. Alfred Alfred
Cloughesy, Timothy Francis
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
[9] A GLOBAL EXPANSION OF GBM AGILE: A PHASE 2/3 ADAPTIVE PLATFORM TRIAL TO EVALUATE MULTIPLE REGIMENS IN NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA
Weller, M.
Berry, D.
Blondin, N.
Boulmay, B.
Buxton, M.
Chinot, O.
Colman, H.
de la Fuente, M.
de Groot, J.
Drappatz, J.
Ducray, F.
Ellingson, B.
Galldiks, N.
Gordon, G.
Hau, P.
Hottinger, A.
Hyddmark, V
Khasraw, M.
Kim, L.
Lassman, A.
Lee, E.
Lim, M.
Mellinghoff, I
Mikkelson, T.
Nghiemphu, P.
Perry, J.
Ronellenfitsch, M.
Sulman, E.
Tabatabai, G.
Tanner, K.
Touat, M.
Wen, P. Y.
Wick, A.
Yung, W.
Cloughesy, T.
NEURO-ONCOLOGY, 2024, 26
[10] GBM AGILE: A global, phase II/III adaptive platform trial to evaluate multiple regimens in newly diagnosed and recurrent glioblastoma.
Buxton, Meredith Becker
Alexander, Brian Michael
Berry, Donald A.
Cavenee, Webster K.
Colman, Howard
De Groot, John Frederick
Ellingson, Benjamin M.
Gordon, Gary B.
Khasraw, Mustafa
Lassman, Andrew B.
Li, Wenbin
Lim, Michael
Mellinghoff, Ingo K.
Perry, James R.
Sulman, Erik P.
Tanner, Kirk
Weller, Michael
Wen, Patrick Y.
Yung, W. K. Alfred
Cloughesy, Timothy Francis
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)

← 1 2 3 4 5 →